| DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, is a putative tumor suppressor | None |
| Expression of the A-raf proto-oncogene in the normal adult and embryonic mouse. | None |
| ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf. | None |
| Detailed genetic mapping of the A-raf proto-oncogene on the mouse X chromosome. | None |
| The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus. | None |
| A-raf oncogene localizes on mouse X chromosome to region some 10-17 centimorgans proximal to hypoxanthine phosphoribosyltransferase gene. | None |
| Characterization of murine A-raf, a new oncogene related to the v-raf oncogene. | None |
| Actively transcribed genes in the raf oncogene group, located on the X chromosome in mouse and human. | None |
| Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. | None |
| Transcriptional regulation of the Drosophila-raf proto-oncogene by the DNA replication-related element (DRE)/DRE-binding factor (DREF) system. | None |
| Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. | None |